Editorial Expression of Concern: Safety of targeting tumor endothelial cell antigens

Affiliations

¹ Batu Biologics, Inc, 9255 Towne Center Drive, #450, San Diego, CA, 92121, USA.
² Medistem Panama, Panama City, Panama.
³ Batu Biologics, Inc, 9255 Towne Center Drive, #450, San Diego, CA, 92121, USA. thomas.ichim@gmail.com.
⁴ Pan Am Cancer Treatment Center, Tijuana, Mexico.
⁵ Medical School, Tecnologico de Monterrey, Monterrey, Mexico.
⁶ Centre for Molecular and Cell-Based Therapeutics, SA de CV, Monterrey, Mexico.
⁷ University of Utah School of Medicine, Salt Lake City, UT, USA.
⁸ John Wayne Cancer Centre, Santa Monica, CA, USA.

^# Contributed equally.

Samuel C Wagner et al. J Transl Med. 2025.

. 2025 Jun 2;23(1):607.

doi: 10.1186/s12967-025-06651-8.

¹ Batu Biologics, Inc, 9255 Towne Center Drive, #450, San Diego, CA, 92121, USA.
² Medistem Panama, Panama City, Panama.
³ Batu Biologics, Inc, 9255 Towne Center Drive, #450, San Diego, CA, 92121, USA. thomas.ichim@gmail.com.
⁴ Pan Am Cancer Treatment Center, Tijuana, Mexico.
⁵ Medical School, Tecnologico de Monterrey, Monterrey, Mexico.
⁶ Centre for Molecular and Cell-Based Therapeutics, SA de CV, Monterrey, Mexico.
⁷ University of Utah School of Medicine, Salt Lake City, UT, USA.
⁸ John Wayne Cancer Centre, Santa Monica, CA, USA.

^# Contributed equally.

No abstract available

Expression of concern for

Safety of targeting tumor endothelial cell antigens.
Wagner SC, Riordan NH, Ichim TE, Szymanski J, Ma H, Perez JA, Lopez J, Plata-Munoz JJ, Silva F, Patel AN, Kesari S. Wagner SC, et al. J Transl Med. 2016 Apr 12;14:90. doi: 10.1186/s12967-016-0842-8. J Transl Med. 2016. PMID: 27071457 Free PMC article. Review.